[Levovist]
- PMID: 9577601
[Levovist]
Abstract
SH/TA-508 (Levovist) is agglomerates of microparticles consisting of galactose (99.9%) and palmitic acid (0.1%), and the active entity is the microbubbles stabilized by palmitic acid which covers the bubbles. SH/TA-508 micro-bubbles are stable under high-pressure condition and they circulate the whole body for several minutes along with blood flow after the intravenous injection. The left sided cardiac cavities and arteries are clearly opacified by using this contrast agent and the Doppler signals from the mitral, aortic and pulmonic vein are also enhanced significantly. Also microcirculating flow image of the liver, kidney and other organs are well enhanced in the clinical studies. SH/TA-508 improves the capability of ultrasound diagnosis.
Similar articles
-
Saccharide-based contrast agents. Characteristics and diagnostic potential.Radiol Med. 1994 May;87(5 Suppl 1):15-23. Radiol Med. 1994. PMID: 8209013 Review. English, Italian.
-
Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology.J Neuroimaging. 1997 Apr;7 Suppl 1:S2-14. J Neuroimaging. 1997. PMID: 9128460 Review.
-
Suitable solutions for reconstituting the ultrasound contrast agent "Levovist" used in contrast echocardiogram: in vitro and in vivo evaluation of the influence of osmotic pressure.Int J Cardiol. 2009 Aug 21;136(3):335-40. doi: 10.1016/j.ijcard.2008.05.043. Epub 2008 Aug 3. Int J Cardiol. 2009. PMID: 18678422 Clinical Trial.
-
[Effect of oxygen inhalation on myocardial opacification using levovist: an animal experimental study].J Cardiol. 2001 Jun;37(6):335-40. J Cardiol. 2001. PMID: 11433809 Japanese.
-
[Perfusion imaging of the kidney using contrast-enhanced phase-inversion ultrasound].Rontgenpraxis. 2004;55(5):167-74. Rontgenpraxis. 2004. PMID: 15700653 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources